The SCCT Global 2026 | Hong Kong meeting Organizing Committee welcomes submission of abstracts for original contribution to the field for poster presentations. 

Presenters of accepted abstracts are required to register for and attend SCCT Global 2026 meeting. All accepted abstracts will be published in an online supplement of the Journal of Cardiovascular Computed Tomography (JCCT) .

Submit your abstract

Guidelines and tips

Start preparing now to present your work at this premier cardiovascular CT event. Review the following guidelines and tips for successful abstracts. 

• SCCT abstract guidelines

Key dates for the SCCT Global 2026 | Hong Kong abstract program

When submitting an abstract to any SCCT Meeting, the First Authors agree to the Prior Presentation/Publication Policy and Embargo Policy on behalf of all parties involved with the work on which the abstract is based. The First Author is responsible for communicating the policies to all involved parties, including co-authors and grantors, complying with these policies, and will be held accountable for any policy violations of the abstract.

Prior to the SCCT Meeting, the contents and conclusions of the abstract must not be presented at or published in conjunction with any scientific, medical, or educational meeting with the exception of study results presented at closed (non-public) meetings, such as investigator or cooperative group meetings, so long as no meeting materials are publicly disseminated. In addition, the contents and conclusions of the abstract are embargoed and must not be published in a scientific, medical, or educational publication (in any medium), in whole or in part, before the abstract is published online by SCCT and/or presented at the SCCT Meeting to which it was submitted.

Once an abstract has been publicly released by SCCT and the embargo has lifted, you may widely distribute a press release containing the full data, including any additional or updated data that will be presented at the meeting even if not included in the abstract itself.

Commercial Relationship Disclosure Procedures

• All financial relationships with commercial interests relevant to the research reported in the abstract must be disclosed.
• As the First Author, it is your responsibility to provide all commercial relationship disclosures for yourself during the abstract acceptance process.
• Relevant non-remunerative positions that may create a conflict of interest must also be reported.

Ming-Yen Ng, MBBS, FSCCT, chair

 Submit your abstract

REGISTER FOR MEETING

For additional information, please email education@scct.org.